The Illustrious Medical Research Career of Scott Rocklage, Ph.D.

Scott Rocklage rose to the level of a Managing Partner within the first year working at the Venture Capitalist firm, 5AM Ventures Inc. The revered researcher, Dr. Scott spent over thirty plus years, leading some of America’s leading pharmaceutical giants.

Scott M. Rocklage, Ph.D. is an accomplished research professor who’s played an instrumental role in the successful development of drugs that ended up saving millions of lives, the world over.

Rocklage led a research team of scientists who developed the FDA approved drug applications retailing worldwide under the following generic labels: Cubicin, Teslascan, and Omniscan.

President and CEO, Scott Rocklage

Scott M. Rocklage, Ph.D. has previously served as the Chairman, CEO or President of the following publicly traded biotechnology research institutes and pharmaceutical companies. Nycomed Salutar, Cubic Pharmaceuticals, Catalytica, Relypsa, Rennovia, Pulmatric, Novira and at Cidara the Nasdaq pharmaceutical giant trading under the initials CDTX.

Educational Backgroung

Professor Scott studied for his undergraduate degree at UCLA’s Berkeley University. Dr. Scott graduated with a first-class Bachelor of Science degree in Chemistry. He would eventually pursue his masters and Ph.D. in drug research and development at the respected MIT.

Professor Scott is said to have shared laboratory premises with the 2005 Chemistry Nobel Prize winner, Professor. Richard R. Schrock.

Published Medical Journals

The eminent researcher, Dr. Scott Rocklage has published a ton of medical groundbreaking research findings over the decades. The over 30 U.S Medical patents to his name are a clear testament to Dr. Scott’s immense contribution to the pharmaceutical realm. Read more: Scott Racklage | Bloomberg

Recently, MIT erected a plaque in honor of the lifetime achievements of Professor Scott. The scientists graced the auspicious event accompanied by his lifetime lover and wife.

Interview with Dr. Scott Rocklage

According to a candid interview with, Scott Rocklage offers remarkable advice to aspiring investors and entrepreneurs. Scott Rocklage comes across as a very organized individual who takes great pride in investing in skilled people.

He reminds us of the value and importance of staying true to the course no matter the prevailing circumstances.

The problem, according to Scott, with many aspiring investors is that they tend to focus on the short-term instead of paying emphasis on the long-term goals and objectives of the business.

His advice to us is that we ought to take bold but calculated risks and make sure we have the right team and the rest falls into place just perfectly.

Jeffry Schneider Suggests Alternative Investment Plans that will Grow Your Business Assets

Jeffry Schneider prides himself as a seasoned alternative investment financial expert and a cheerful philanthropist. As the CEO of Ascendant Capital LLC, he has managed to grow a large portfolio of prominent clients, generated impressive figures and managed to keep his employees happy. Jeffry also works with several charitable organizations as his way of giving back.

When Mr. Schneider decided to launch Ascendant Capital, he had spotted a unique opportunity within the investment industry. He understood that wealthy individuals and large corporations were looking for ways to diversify their investment portfolio whilst reducing risk. This is how he came up with the idea of providing alternative investment strategies.

Ascendant Capital is based in Austin with over 30 full time employees who are financial and structural professionals. Through Schneider’s leadership, the Ascendant team plays an important role of sourcing, structuring and supporting alternative investment ideas they believe are going to be beneficial to their clientele. Mr. Schneider himself has over 24 years experience as a provider of financial investment solutions, thus his leadership is highly respected at Ascendant Capital.

On business days, behind his CEO desk, Jeffry Schneider is tasked with the role of finding new strategies to raise capital for their established or emerging alternative investment fund sponsors. Jeffry strongly believes teamwork is necessary to push your goals forward, thus he frequently partners with other industry players to push the products to a global scale to both private and public clienteles. On his business network, Schneider partners with family offices, private banks, broker dealers and even fellow registered investment advisors.

As we all know that numbers don’t lie, Ascendant capital has grown quite an impressive performance record over the past 5 years. Jeffry Schneider together with his ingenious team of professional financial experts have managed to raise almost $1 billion in funding to alternative asset funding sponsors. Ascendant’s business network has grown to over 50 brokers and 250 private investment advisory companies whom they closely work with.

With the raised funds, Ascendant Capital has succeeded in making lucrative investments in real estate, auto dealerships and technology on behalf of his clients. This is just a tip of the ice berg according to the team at Ascendant Capital as they are looking forward to surpass the $1 billion funding mark and create fresh investment strategies.

About Jeffry Schneider

Jeffry Schneider is the founder and CEO of Ascendant Capital LLC, a team of financial experts experienced in providing alternative investment packages to a prominent clientele. Prior to launching Ascendant Capital, Jeffry was an employee at Paradigm Global Advisors and Axiom Capital Management. He has also worked at Alex Brown, Merrill Lynch and Smith Barney where he gathered his extensive knowledge in financial and investment strategies.

Jeffry Schneider is also a philanthropist and is passionately involved in a number of charitable projects. He partners with organizations like Gazelle Foundation, Wonders and Worries, and Cherokee Home for Children.